“Our clients in regulated industries face potential litigation at every turn. My job is not only to defend those cases, but to reduce your risk of being sued in the first place. It starts with an efficient risk-management plan and a knowledgeable, science-based response to demand letters and prelitigation notices and claims. But if you are sued, you will need an experienced litigator who understands the science and the regulatory environment and who will represent you zealously and efficiently. That’s what I strive to do.”
As head of our litigation practice, Jennifer successfully represents clients in regulated industries in all types of litigation, from class actions and consumer claims to unfair trade practices to disputes between businesses.
Jennifer brings to her practice a unique knowledge of litigation and regulation in both practice and theory. Previously a litigation partner at a complex litigation firm in the areas of mass torts, securities, consumer protection, and antitrust, Jennifer developed a specialty in litigation involving regulated industries. She played an active role investigating and litigating science issues, including trial, in the Vioxx multi-district litigation and the Engle tobacco litigation, litigated a nationwide class action against Mercedes Benz USA from class certification to settlement, and administered the class settlements in four statewide antitrust class actions against Microsoft.
Prior to joining Olsson Frank Weeda, Jennifer was selected by the Institute of Medicine and FDA for a highly competitive fellowship in regulatory science. While at FDA, she drafted agency guidances and conducted legal analysis of proposed regulations under the Administrative Procedure Act and the Constitution, including First Amendment issues pertaining to warning and label requirements and due process concerns. Her analysis of these issues is published in the preamble of the deeming rule.
Jennifer also brings extensive experience in law and economics. A former doctoral fellow at the RAND Corporation, Jennifer is a coauthor of the legal textbook Class Action Dilemmas – Pursuing Public Goals for Private Gain, the culmination of a multi-year, multi-disciplinary study of class actions. She also co-authored a major study of asbestos litigation presented to the judicial committees of the United States Senate and House of Representatives. Jennifer’s quantitative skills, including multivariable statistics, are particularly valuable in cases involving regulated products and class allegations.
Every food or agriculture company that gets serious about Washington eventually faces the same choice: hire a lobbying firm, or hire a government relations attorney.
On October 19, 2026, the U.S. Food and Drug Administration (FDA) announced the availability of a guidance for industry entitled “New Dietary Ingredient (NDI) Notifications
Your regulatory affairs team fields FDA warning letters and USDA inspection findings as a matter of routine, often through the firm’s broader agriculture and agribusiness
